Hôpital Armand-Trousseau

Running trials

• Recruiting

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Recruiting

  A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

  NCT07306832· Phase 1· AbbVie· Source

• Recruiting

  Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia

  NCT07483476· Assistance Publique - Hôpitaux de Paris· Source

• Not yet recruiting

  Factors Associated With Blood Pressure Control Failure to Intravenous Labetalol in Severe Preeclampsia

  NCT07547046· Assistance Publique - Hôpitaux de Paris· Source

• Not yet recruiting

  Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.

  NCT07111117· Phase 2· Institut Curie· Source

• Not yet recruiting

  Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura

  NCT07310342· University Hospital, Bordeaux· Source

• Recruiting

  A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

  NCT07054515· Phase 3· Azafaros B.V.· Source

• Active, not recruiting

  A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

  NCT06953583· Phase 3· Biogen· Source

• Recruiting

  Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data

  NCT06380192· Imagine Institute· Source

• Recruiting

  A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

  NCT06439277· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

  NCT05983991· Institut Claudius Regaud· Source

• Recruiting

  SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

  NCT05192980· Institut Curie· Source

• Recruiting

  Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology

  NCT05625724· Phase 3· University Hospital, Toulouse· Source

• Recruiting

  Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)

  NCT05521776· Assistance Publique - Hôpitaux de Paris· Source

• Recruiting

  MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2

  NCT05691608· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Recruiting

  Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

  NCT04477681· Gustave Roussy, Cancer Campus, Grand Paris· Source

• Recruiting

  Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

  NCT03934372· Phase 1/2· Incyte Biosciences International Sàrl· Source

• Recruiting

  Natural History of Duchenne Muscular Dystrophy

  NCT03882827· Genethon· Source

• Active, not recruiting

  Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

  NCT03496402· Institut Curie· Source

• Recruiting

  IDMet (RaDiCo Cohort) (RaDiCo-IDMet)

  NCT05945576· Institut National de la Santé Et de la Recherche Médicale, France· Source

• Active, not recruiting

  National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

  NCT02867033· Centre Oscar Lambret· Source

• Recruiting

  French Childhood Cancer Survivor Study

  NCT01620372· Institut National de la Santé Et de la Recherche Médicale, France· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers9 recruiting
• Acute myeloid leukaemia3 recruiting
• Acute lymphoblastic leukaemia2 recruiting
• Neuroblastoma2 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Epilepsy1 recruiting
• High blood pressure1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Myelodysplastic syndromes1 recruiting
• Sarcoma1 recruiting

Closed trials

• Completed

  Perinatal Thoraco-abdomino-pelvic Tumors Study

  NCT06365268· Assistance Publique - Hôpitaux de Paris· Source

• Completed

  Diaphyseal Reconstruction of Malignant Tumors in Children

  NCT06361290· Assistance Publique - Hôpitaux de Paris· Source

• Completed

  EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

  NCT05093634· Phase 3· Rhythm Pharmaceuticals, Inc.· Source

• Completed

  Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

  NCT05156320· Phase 3· Scholar Rock, Inc.· Source

• Completed

  Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings

  NCT04969601· Phase 1/2· Assistance Publique - Hôpitaux de Paris· Source

• Completed

  Home Airway Clearance in CF Patients

  NCT04096664· Physio-Assist· Source

• Recruiting

  A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

  NCT03969329· Phase 3· Amgen· Source

• Terminated

  MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis

  NCT03357562· University Hospital, Bordeaux· Source

• Completed

  Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy

  NCT02913482· Phase 2· Hoffmann-La Roche· Source

• Completed

  Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)

  NCT02500381· Phase 3· Sarepta Therapeutics, Inc.· Source

• Completed

  Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents

  NCT02684708· Phase 3· University of Giessen· Source

• Completed

  Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

  NCT02369731· PTC Therapeutics· Source

• Completed

  Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

  NCT02303821· Phase 1· Amgen· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Duchenne muscular dystrophy5 works · 3 trials
• Spinal muscular atrophy5 works · 2 trials